CLINICAL_TRIALS
trial_result
· 2016-06-27
Clinical Trial Update: A Single Rising Dose Study of MK-8150 (MK-8150-001) [Phase 1]
Summary
Phase 1 single rising dose study of MK-8150 completed; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension, Isolated Systolic Hypertension (ISH) | Phase 1 | Status: COMPLETED | Results posted: 2016-06-27